Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Daniel M. Labow

Dr. Daniel M. Labow

Associate Professor of Surgery

Surgeon Dr. Daniel M. Labow is an advocate of hyperthermic intraperitoneal chemotherapy for patients with peritoneal mesothelioma, and started the HIPEC program at Mount Sinai Medical Center.

Get in touch
Jump to a Topic:

About Daniel M. Labow

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Top Doctor icon

    Top Doctor

  • Research Excellence icon

    Excellence in Research

  • Minimally Invasive Surgery icon

    Minimally Invasive Surgery

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

Get to Know Dr. Daniel Labow

Dr. Daniel M. Labow, a native of Canada, received his medical degree from Brown University after attending the University of Pennsylvania. He did a surgical residency at University of Chicago and completed a surgical oncology fellowship at Memorial Sloan Kettering in New York. He joined Mount Sinai Medical Center, which includes both the hospital and school of medicine, in 2004.

Just a few years later, he started the hyperthermic intraperitoneal chemotherapy program in 2007 at Mount Sinai Medical Center in New York, and has watched the program grow rapidly with success stories that include mesothelioma patients.

“It is not the one silver bullet that everyone wants to find, and it doesn’t apply to everyone,” Labow told “But, it certainly has become an important part of treatment for many.”

Labow uses HIPEC with cytoreductive surgery on patients with mesothelioma, colorectal cancer, stomach cancer, cancer of the appendix, ovarian cancer and other cancers confined to the peritoneal cavity.

He spends much of his time working on the diagnosis and treatment of primary and metastatic malignancies, including gastric and esophageal cancer and pancreatic and liver malignancies. He has worked extensively with minimally invasive surgical techniques.

Labow has performed close to 200 HIPEC procedures since starting the program at Mount Sinai.

Doctor talking to patients

Get the Best Treatment

Get help connecting with Dr. Labow and find the treatment that's best for you.

Get Help Now

Specialties of Dr. Daniel Labow

  • Peritoneal mesothelioma

  • Minimally invasive surgery

  • Hyperthermic intraperitoneal chemotherapy

Dr. Daniel Labow’s Experience and Medical Education

  • Dartmouth-Brown Medical Program at Brown University (Medical school)

  • University of Chicago (Residency)

  • Memorial Sloan Kettering Cancer Center (Fellowship)

Dr. Daniel Labow’s Awards and Certifications

  • 2013 Best Doctors, New York magazine

  • 2011 Top Doctors — New York Metro Area Award, named by Castle Connolly

  • 2007 Robert Paradny Teaching Award

  • University of Chicago Hospitals administrative chief resident, 2001

  • Memorial Sloan Kettering Cancer Center chief research fellow, 1998

Testimonials for Dr. Daniel Labow

“Nothing in life is a guarantee, but the guarantee for me was that HIPEC was the best treatment,” said Rosanne Mari, a patient from New Jersey who had the procedure in combination with cancer surgery. “I am a better, healthier person, and for that I am forever grateful to Dr. Labow.”

See More Top Mesothelioma Doctors

Publications of Dr. Daniel Labow

  • Labow, D.M. et al. (2020). Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies? World Journal of Surgical Oncology.

  • Sarpel, U. et al. (2020). The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World Journal of Surgical Oncology.

  • Sullivan, B.J. et al. (2020). Distal pancreatectomy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Identifying risk and improving patient selection. The American Journal of Surgery.

Disclaimer: Dr. Daniel M. Labow has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

3 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Mount Sinai. (2020). HIPEC.
    Retrieved from:
  2. Labow, D. (2013, February 13). Daniel Labow interview with
  3. Mount Sinai Doctors. (n.d.). Daniel M Labow, MD.
    Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 15, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now